Insider Transactions in Q4 2025 at Guardant Health, Inc. (GH)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 17
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
232
+15.0%
|
-
|
|
Oct 17
2025
|
Myrtle S Potter Director |
SELL
Open market or private sale
|
Direct |
26
-0.14%
|
$1,716
$66.95 P/Share
|
|
Oct 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-1.48%
|
$7,656
$66.95 P/Share
|
|
Oct 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.37%
|
-
|
|
Oct 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+3.09%
|
-
|
|
Oct 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,025
-13.68%
|
$435,550
$62.65 P/Share
|
|
Oct 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,859
+8.35%
|
-
|
|
Oct 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,740
-9.09%
|
$355,880
$62.65 P/Share
|
|
Oct 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,550
+6.75%
|
-
|
|
Oct 01
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,348
-18.0%
|
$331,576
$62.65 P/Share
|
|
Oct 01
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,549
+10.94%
|
-
|
|
Oct 01
2025
|
Terilyn J. Monroe Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,310
-16.91%
|
$329,220
$62.65 P/Share
|
|
Oct 01
2025
|
Terilyn J. Monroe Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,477
+25.02%
|
-
|
|
Oct 01
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,431
-12.47%
|
$460,722
$62.65 P/Share
|
|
Oct 01
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,167
+7.2%
|
-
|
|
Oct 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.57%
|
$754,044
$62.65 P/Share
|
|
Oct 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+1.1%
|
-
|
|
Oct 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.61%
|
$754,044
$62.65 P/Share
|
|
Oct 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+1.18%
|
-
|
|
Oct 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,695
-12.86%
|
$477,090
$62.65 P/Share
|
|
Oct 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,181
+11.12%
|
-
|
|
Oct 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,163
-8.37%
|
$506,106
$62.65 P/Share
|
|
Oct 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,104
+5.12%
|
-
|